LumiraDx SARS-CoV-2 RNA STAR Complete is a rapid nucleic acid amplification method for the qualitative detection of SARS-CoV-2 in upper respiratory specimens from individuals suspected of COVID-19. It utilizes a direct amplification method that combines lysis and amplification in a single step, without needing to perform any specimen purification and extraction in under 20 minutes.
Benefits of SARS-CoV-2 RNA STAR Complete
Rapid : Reduces molecular laboratory workflow from approximately 3 hours to under 20 minutes
Accessible : Allows existing labs to use current infrastructure and achieve high throughput testing
Efficiency : Provides approximately a 6- to 8- fold increase of testing throughput over common open molecular systems
Supply : Eliminates need for sample preparation instrumentation and reagents
LumiraDx SARS-CoV-2 RNA STAR Complete will enable laboratories to improve throughput by using current molecular infrastructure and eliminating the need for extraction and purification.